Contact Us

News Releases ::

• Isotechnika Pharma and 3SBio Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
  More...August 24, 2010
  
• Isotechnika reports second quarter 2010 financial results
  More...August 11, 2010
  
• Lux Biosciences receives Complete Response letter from FDA for voclosporin
  More...August 4, 2010
  

Media Coverage ::

• Pharma Watch: 3SBio, Isotechnika Partner on Voclosporin
  More...August 25, 2010
• Isotechnika lands China deal
  More...August 25, 2010
• Isotechnika Pharma signs $6m commercialization agreement for transplant organ rejection drug with 3SBio in China
  More...August 24, 2010

Events ::

• Annual & Special Meeting
  More...September 9, 2010

Contact Us

Contact Information

Isotechnika Pharma Inc.
5120 - 75th Street
Edmonton, Alberta
T6E 6W2

Telephone: (780) 487-1600
Fax:(780) 484-4105

E-mail:
Human Resources
Investor Relations
businessdevelopment@isotechnika.com
clinicaltrials@isotechnika.com